Revista Brasileira de Hematologia e Hemoterapia
Elsevier
About the journal
Revista Brasileira de Hematologia e Hemoterapia is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 21 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 1516-8484 · 1806-0870
- Country
- Netherlands
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 1726
- Declared review time
- 21 weeks
- Declared peer-review model
- double_blind
Index listings
- DOAJ · 2004-04-23
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 21 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Dormant — no works recorded since 2017
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1726
Most recent article
5 years ago
Average review time (journal-declared via DOAJ)
21weeks
Works in OpenAlex
1875
Last recorded publication year
2017
h-index
46
i10-index
437
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2025-06-23
- Added to DOAJ
- 2004-04-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Continued by
- 2531-1379, 2531-1387
- Source type
- journal
- NLM unique ID (PubMed)
- 101220159
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Iron Metabolism and Disorders
- Iron Metabolism and Disorders
- Blood groups and transfusion
- Hematopoietic Stem Cell Transplantation
- Blood transfusion and management
Show all subjects (75)
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Blood donation and transfusion practices
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Iron Metabolism and Disorders
- Chronic Lymphocytic Leukemia Research
- Blood groups and transfusion
- Blood groups and transfusion
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Hematological disorders and diagnostics
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Blood donation and transfusion practices
- Blood donation and transfusion practices
- Retinoids in leukemia and cellular processes
- Acute Lymphoblastic Leukemia research
- Chronic Myeloid Leukemia Treatments
- Clinical Laboratory Practices and Quality Control
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Blood transfusion and management
- Blood transfusion and management
- Hemoglobin structure and function
- Malaria Research and Control
- Multiple Myeloma Research and Treatments
- Neonatal Health and Biochemistry
- T-cell and Retrovirus Studies
- T-cell and Retrovirus Studies
- Mesenchymal stem cell research
- Viral-associated cancers and disorders
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Neonatal Health and Biochemistry
- Neonatal Health and Biochemistry
- Hemophilia Treatment and Research
- Neutropenia and Cancer Infections
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Maternal and Neonatal Healthcare
- Maternal and Neonatal Healthcare
- Erythrocyte Function and Pathophysiology
- Erythrocyte Function and Pathophysiology
- Viral-associated cancers and disorders
- Neutropenia and Cancer Infections
- Childhood Cancer Survivors' Quality of Life
- Viral-associated cancers and disorders
- Childhood Cancer Survivors' Quality of Life
- Neutropenia and Cancer Infections
- Blood properties and coagulation
- Science and Education Research
- Science and Education Research
- Folate and B Vitamins Research
- Folate and B Vitamins Research
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Mesenchymal stem cell research
- Mesenchymal stem cell research
Keywords (DOAJ)
- health sciences
- hematology
- case reports
- hemotherapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ